Antibacterial Effect of Iodine-Based Paste With Silver Nanoparticles Against Enterococcus faecalis: An In Vitro Study
Abstract
Background: Pulpectomy is one of the most common treatments for the rehabilitation and conservation of primary dentition. This procedure requires thorough disinfection of the root canals to eliminate the bacterial load prior to obturation. However, the anatomical complexity of primary root canals limits the complete eradication of certain bacteria, such as Enterococcus faecalis (E. faecalis). Although iodine-based pastes, such as Vitapex, are considered the gold standard for primary root canal fillings due to their excellent clinical outcomes, the extent of their antibacterial efficacy remains unclear.
Objective: To evaluate the antibacterial efficacy of an iodine-based paste incorporated with silver nanoparticles against E. faecalis.
Design: This experimental study employed a comparative, cross-sectional, analytical, and prospective design.
Methods: Silver nanoparticles (AgNPs) were synthesized and chemically characterized prior to incorporation into an iodoform paste (Vitapex). The antibacterial efficacy was subsequently evaluated across three distinct groups: Group 1 (Vitapex), Group 2 (AgNPs), and Group 3 (Vitapex with AgNPs). Experiments were performed in triplicate using the E. faecalis ATCC 29212 strain to measure the zones of inhibition for each group.
Results: Significant statistical differences were observed (p = 0.003) in the inhibition zones against E. faecalis. The antibacterial activity of the Vitapex+AgNPs combination (SD 13.93 ± 0.83) was significantly higher…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.